Does ERIBULIN Cause Neoplasm progression? 126 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 126 reports of Neoplasm progression have been filed in association with ERIBULIN (eribulin mesylate). This represents 2.5% of all adverse event reports for ERIBULIN.
126
Reports of Neoplasm progression with ERIBULIN
2.5%
of all ERIBULIN reports
32
Deaths
21
Hospitalizations
How Dangerous Is Neoplasm progression From ERIBULIN?
Of the 126 reports, 32 (25.4%) resulted in death, 21 (16.7%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERIBULIN. However, 126 reports have been filed with the FAERS database.
What Other Side Effects Does ERIBULIN Cause?
Neutropenia (675)
Malignant neoplasm progression (594)
Myelosuppression (520)
Febrile neutropenia (448)
Neutrophil count decreased (294)
Neuropathy peripheral (290)
White blood cell count decreased (289)
Pyrexia (275)
Disease progression (211)
Fatigue (209)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which ERIBULIN Alternatives Have Lower Neoplasm progression Risk?
ERIBULIN vs ERLOTINIB
ERIBULIN vs ERTAPENEM
ERIBULIN vs ERTUGLIFLOZIN PIDOLATE
ERIBULIN vs ERYTHROMYCIN
ERIBULIN vs ERYTHROMYCIN ETHYLSUCCINATE